Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 3, 2006, Pages 545-551

  Taguchi, Ayumu ^a   Ohmiya, Naoki ^a   Itoh, Akihiro ^a   Hirooka, Yoshiki ^b   Niwa, Yasumasa ^a   Mori, Naoyoshi ^a   Goto, Hidemi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Antiparietal cell antibody; Atrophic gastritis; Gastric carcinoma; Helicobacter pylori; p53 mutation

Indexed keywords

IMMUNOGLOBULIN G; PARIETAL CELL ANTIBODY; PEPSINOGEN; PROTEIN P53;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ATROPHIC GASTRITIS; CANCER GENETICS; CANCER GROWTH; CANCER SUSCEPTIBILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; STOMACH CARCINOGENESIS;

EID: 33645037326     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03983.x     Document Type: Article

References (41)

1. Parsonnet J Friedman GD Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma NEnglJMed 1991 325 1127 31
2. Correa P Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res 1992 52 6735 40
3. Correa P Haenszel W Cuello C Tannenbaum S Archer M A model for gastric cancer epidemiology Lancet 1975 2 58 60
4. Sipponen P Kekki M Haapakoski J Ihamaki T Siurala M Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data IntJCancer 1985 35 173 7
5. Uemura N Okamoto S Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer NEnglJMed 2001 345 784 9
6. Correa P Shiao YH Phenotypic and genotypic events in gastric carcinogenesis Cancer Res 1994 54 S1941 3
7. Samloff IM Varis K Ihamaki T Siurala M Rotter JI Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia Gastroenterology 1982 83 204 9
8. Varis K Kekki M Harkonen M Sipponen P Samloff IM Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer ScandJGastroenterolSuppl 1991 186 117 23
9. Miki K Ichinose M Ishikawa KB et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer Jpn JCancer Res 1993 84 1086 90
10. Knight T Wyatt J Wilson A et al. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: Development of a biomarker strategy for gastric atrophy in high risk groups BrJCancer 1996 73 819 24
11. Watanabe Y Kurata JH Mizuno S et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan DigDisSci 1997 42 1383 7
12. Kitahara F Kobayashi K Sato T Kojima Y Araki T Fujino MA Accuracy of screening for gastric cancer using serum pepsinogen concentrations Gut 1999 44 693 7
13. Faller G Steininger H Eck M Hensen J Hann EG Kirchner T Antigastric autoantibodies in Helicobacter pylori gastritis: Prevalence, in-situ binding sites and clues for clinical relevance Virchows Arch 1996 427 483 6
14. Valle J Kekki M Sipponen P Ihamaki T Siurala M Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study ScandJGastroenterol 1996 31 546 50
15. Faller G Steininger H Kranzlein J et al. Antigastric autoantibodies in Helicobacter pylori infection: Implications of histological and clinical parameters of gastritis Gut 1997 41 619 23
16. Claeys D Faller G Appelmelk BJ Negrini R Kirchner T The gastric H+, K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy Gastroenterology 1998 115 340 7
17. Vorobjova T Faller G Maaroos HI et al. Significant increase in antigastric autoantibodies in a long-term follow-up study of H. pylori gastritis Virchows Arch 2000 437 37 45
18. Oksanen A Sipponen P Karttunen R et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy Gut 2000 46 460 3
19. Samloff IM Pepsinogens I and II: Purification from gastric mucosa and radioimmunoassay in serum Gastroenterology 1982 82 26 33
20. Negrini R Savio A Poiesi C et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis Gastroenterology 1996 111 655 65
21. Appelmelk BJ Simoons-Smit I Negrini R et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity InfectImmun 1996 64 2031 40
22. Aspinall GO Monteiro MA Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: Structures of the O antigen and core oligosaccharide regions Biochemistry 1996 35 2498 504
23. Simoons-Smit IM Appelmelk BJ Verboom T et al. Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide JClinMicrobiol 1996 34 2196 200
24. Fong TL Dooley CP Dehesa M et al. Helicobacter pylori infection in pernicious anemia: A prospective controlled study Gastroenterology 1991 100 328 32
25. Haruma K Komoto K Kawaguchi H et al. Pernicious anemia and Helicobacter pylori infection in Japan: Evaluation in a country with a high prevalence of infection AmJGastroenterol 1995 90 1107 10
26. Sjoblom SM Sipponen P Jarvinen H Gastroscopic follow up of pernicious anaemia patients Gut 1993 34 28 32
27. Hsing AW Hansson LE McLaughlin JK et al. Pernicious anemia and subsequent cancer. A population-based cohort study Cancer 1993 71 745 50
28. Kokkola A Sjoblom SM Haapiainen R Sipponen P Puolakkainen P Jarvinen H The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study ScandJGastroenterol 1998 33 88 92
29. Lauren P The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta PatholMicrobiolScand 1965 64 31 49
30. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma - 2nd English edition Gastric Cancer 1998 1 10 24
31. Marchildon PA Sugiyama T Fukuda Y et al. Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection JClinMicrobiol 2003 41 1480 5
32. Ohmiya N Matsumoto S Yamamoto H Baranovskaya S Malkhosyan SR Perucho M Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype Gene 2001 272 301 13
33. Kuipers EJ Pena AS van Kamp G et al. Seroconversion for Helicobacter pylori Lancet 1993 342 328 31
34. Kuipers EJ Uyterlinde AM Pena AS et al. Long-term sequelae of Helicobacter pylori gastritis Lancet 1995 345 1525 8
35. Kokkola A Kosunen TU Puolakkainen P et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis APMIS 2003 111 619 24
36. Ohata H Kitauchi S Yoshimura N et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer IntJCancer 2004 109 138 43
37. Ito M Haruma K Kaya S et al. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: Evaluation in a country of high prevalence of atrophic gastritis ScandJGastroenterol 2002 37 287 93
38. Ito M Haruma K Kaya S et al. Implication of anti-parietal cell antibody levels in gastrointestinal diseases, including gastric carcinogenesis DigDisSci 2002 47 1080 5
39. Lee GR Bithell TC Foerster J Athens JW Lukens JN Wintrobe's Clinical Hematology Philadelphia Lea and Febiger 1993
40. Tamura G Kihana T Nomura K Terada M Sugimura T Hirohashi S Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis Cancer Res 1991 51 3056 8
41. Rhyu MG Park WS Jung YJ Choi SW Meltzer SJ Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis Gastroenterology 1994 106 1584 8